Clovis Oncology Receives $20,000,000 New Round

  • Feed Type
  • Date
    6/3/2011
  • Company Name
    Clovis Oncology
  • Mailing Address
    2525 28th Street Boulder, CO 80301
  • Company Description
    Clovis Oncology (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.
  • Website
    http://www.Clovisoncology.com
  • Transaction Type
    Debt
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount may include securities to be acquired upon exercise of option, warrants or other rights to acquire securities. Amount may also include convertible notes. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy